The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients-Reference-Cited by-同舟云学术

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients

Published:2019-05-30 Issue:5 Volume:14 Page:e0217550
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Saleh Moshira Ezzat,Gadalla Ramy,Hassan Hebatallah,Afifi Ahmed,Götte Martin^ORCID,El-Shinawi Mohamed,Mohamed Mona Mostafa,Ibrahim Sherif Abdelaziz^ORCID

Funder

Science and Technology Development Fund

Deutscher Akademischer Austausch Dienst Kairo

H2020 Marie Skłodowska-Curie Actions

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference66 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018

2. Cancer incidence in egypt: results of the national population-based cancer registry program;AS Ibrahim;Journal of cancer epidemiology,2014

3. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways;SA Ibrahim;Molecular cancer,2017

4. Inflammatory breast cancer biology: the tumour microenvironment is key;B Lim;Nature reviews Cancer,2018

5. The role of the cell-cell interactions in cancer progression;K Kaminska;Journal of cellular and molecular medicine,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway;Cancer Cell International;2023-04-17

2. Proteoglycans in breast cancer, identification and characterization by LC‐MS/MS assisted proteomics approach: A review;PROTEOMICS – Clinical Applications;2023-01-11

3. Interleukin-34-regulated T-cell responses in rheumatoid arthritis;Frontiers in Medicine;2022-11-30

4. Matrix proteoglycans in tumor inflammation and immunity;American Journal of Physiology-Cell Physiology;2022-09-01

5. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer;Breast Cancer: Targets and Therapy;2022-09